Fusion gene information | Fusion gene name: FANCA-FANCA |
Fusion gene ID: hg2175tg2175 | | Hgene | Tgene | Gene symbol | FANCA | FANCA | Gene ID | 2175 | 2175 | Gene name | FA complementation group A | FA complementation group A |
Synonyms | FA|FA-H|FA1|FAA|FACA|FAH|FANCH | FA|FA-H|FA1|FAA|FACA|FAH|FANCH |
Cytomap | ('FANCA')('FANCA') 16q24.3 | 16q24.3 |
Type of gene | protein-coding | protein-coding |
Description | Fanconi anemia group A proteinFanconi anemia complementation group AFanconi anemia, complementation group HFanconi anemia, type 1 | Fanconi anemia group A proteinFanconi anemia complementation group AFanconi anemia, complementation group HFanconi anemia, type 1 |
Modification date | 20200313 | 20200313 |
UniProtAcc | . | . |
Ensembl transtripts involved in fusion gene | ENST00000389301, ENST00000389302, ENST00000534992, ENST00000543736, ENST00000563673, ENST00000567284, ENST00000568369, | ENST00000389301, ENST00000389302, ENST00000534992, ENST00000543736, ENST00000563673, ENST00000567284, ENST00000568369,
|
Fusion gene scores | * DoF score | 13 X 12 X 5=780 | 9 X 13 X 6=702 |
# samples | 13 | 15 |
** MAII score | log2(13/780*10)=-2.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/702*10)=-2.22650852980868 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 |
Context | PubMed: FANCA [Title/Abstract] AND FANCA [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | FANCA(89877722)-FANCA(89877617), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FANCA | C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 19 | CLINGEN;GENOMICS_ENGLAND;UNIPROT |
Hgene | FANCA | C1856796 | Estren-Dameshek Variant of Fanconi Anemia | 6 | CLINGEN |
Hgene | FANCA | C1856797 | Estren-Dameshek Variant of Fanconi Pancytopenia | 6 | CLINGEN |
Hgene | FANCA | C0015625 | Fanconi Anemia | 5 | CTD_human;GENOMICS_ENGLAND |
Hgene | FANCA | C0030312 | Pancytopenia | 2 | GENOMICS_ENGLAND |
Hgene | FANCA | C1384666 | hearing impairment | 2 | GENOMICS_ENGLAND |
Hgene | FANCA | C1855710 | Bone marrow hypocellularity | 2 | GENOMICS_ENGLAND |
Hgene | FANCA | C2750866 | Growth retardation, pre- and postnatal | 2 | GENOMICS_ENGLAND |
Hgene | FANCA | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human |
Hgene | FANCA | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Hgene | FANCA | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Hgene | FANCA | C0020459 | Hyperinsulinism | 1 | CTD_human |
Hgene | FANCA | C0023418 | leukemia | 1 | CGI;GENOMICS_ENGLAND |
Hgene | FANCA | C0023465 | Acute monocytic leukemia | 1 | GENOMICS_ENGLAND |
Hgene | FANCA | C0023467 | Leukemia, Myelocytic, Acute | 1 | CGI;GENOMICS_ENGLAND |
Hgene | FANCA | C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
Hgene | FANCA | C0220636 | Malignant neoplasm of salivary gland | 1 | CTD_human |
Hgene | FANCA | C0265219 | Miller Dieker syndrome | 1 | GENOMICS_ENGLAND |
Hgene | FANCA | C1257963 | Endogenous Hyperinsulinism | 1 | CTD_human |
Hgene | FANCA | C1257964 | Exogenous Hyperinsulinism | 1 | CTD_human |
Hgene | FANCA | C1257965 | Compensatory Hyperinsulinemia | 1 | CTD_human |
Hgene | FANCA | C3463824 | MYELODYSPLASTIC SYNDROME | 1 | GENOMICS_ENGLAND |
Hgene | FANCA | C4228778 | Abnormality of radial ray | 1 | GENOMICS_ENGLAND |
Tgene | | C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 19 | CLINGEN;GENOMICS_ENGLAND;UNIPROT |
Tgene | | C1856796 | Estren-Dameshek Variant of Fanconi Anemia | 6 | CLINGEN |
Tgene | | C1856797 | Estren-Dameshek Variant of Fanconi Pancytopenia | 6 | CLINGEN |
Tgene | | C0015625 | Fanconi Anemia | 5 | CTD_human;GENOMICS_ENGLAND |
Tgene | | C0030312 | Pancytopenia | 2 | GENOMICS_ENGLAND |
Tgene | | C1384666 | hearing impairment | 2 | GENOMICS_ENGLAND |
Tgene | | C1855710 | Bone marrow hypocellularity | 2 | GENOMICS_ENGLAND |
Tgene | | C2750866 | Growth retardation, pre- and postnatal | 2 | GENOMICS_ENGLAND |
Tgene | | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human |
Tgene | | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Tgene | | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Tgene | | C0020459 | Hyperinsulinism | 1 | CTD_human |
Tgene | | C0023418 | leukemia | 1 | CGI;GENOMICS_ENGLAND |
Tgene | | C0023465 | Acute monocytic leukemia | 1 | GENOMICS_ENGLAND |
Tgene | | C0023467 | Leukemia, Myelocytic, Acute | 1 | CGI;GENOMICS_ENGLAND |
Tgene | | C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
Tgene | | C0220636 | Malignant neoplasm of salivary gland | 1 | CTD_human |
Tgene | | C0265219 | Miller Dieker syndrome | 1 | GENOMICS_ENGLAND |
Tgene | | C1257963 | Endogenous Hyperinsulinism | 1 | CTD_human |
Tgene | | C1257964 | Exogenous Hyperinsulinism | 1 | CTD_human |
Tgene | | C1257965 | Compensatory Hyperinsulinemia | 1 | CTD_human |
Tgene | | C3463824 | MYELODYSPLASTIC SYNDROME | 1 | GENOMICS_ENGLAND |
Tgene | | C4228778 | Abnormality of radial ray | 1 | GENOMICS_ENGLAND |